First Trust Advisors LP Neurocrine Biosciences Inc Transaction History

First Trust Advisors LP

  • $127 Billion
  • Q3 2025

A detailed history of First Trust Advisors LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, First Trust Advisors LP holds 363,113 shares of NBIX stock, worth $52.6 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
363,113
Previous 423,471 14.25%
Holding current value
$52.6 Million
Previous $53.2 Million 4.23%
% of portfolio
0.04%
Previous 0.04%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
SELL
$123.98 - $146.67 $7.48 Million - $8.85 Million
-60,358 Reduced 14.25%
363,113 $51 Million
Q2 2025

Aug 13, 2025
SELL
$87.54 - $128.18 $14.9 Million - $21.8 Million
-169,884 Reduced 28.63%
423,471 $53.2 Million
Q1 2025

May 14, 2025
BUY
$107.22 - $153.29 $21.3 Million - $30.5 Million
198,703 Added 50.35%
593,355 $65.6 Million
Q4 2024

Feb 13, 2025
SELL
$111.62 - $139.44 $16.7 Million - $20.9 Million
-149,669 Reduced 27.5%
394,652 $53.9 Million
Q3 2024

Nov 13, 2024
BUY
$114.58 - $153.15 $12.7 Million - $17 Million
110,784 Added 25.55%
544,321 $62.7 Million
Q2 2024

Aug 13, 2024
SELL
$130.86 - $143.19 $12.2 Million - $13.3 Million
-93,045 Reduced 17.67%
433,537 $59.7 Million
Q1 2024

May 13, 2024
SELL
$130.4 - $143.74 $8.36 Million - $9.22 Million
-64,143 Reduced 10.86%
526,582 $72.6 Million
Q4 2023

Feb 13, 2024
BUY
$106.07 - $132.76 $13.5 Million - $16.9 Million
127,085 Added 27.41%
590,725 $77.8 Million
Q3 2023

Nov 13, 2023
SELL
$94.02 - $117.1 $6.32 Million - $7.87 Million
-67,244 Reduced 12.67%
463,640 $52.2 Million
Q2 2023

Aug 14, 2023
SELL
$89.53 - $104.87 $12.8 Million - $15 Million
-143,132 Reduced 21.24%
530,884 $50.1 Million
Q1 2023

May 15, 2023
BUY
$94.11 - $123.02 $28,044 - $36,659
298 Added 0.04%
674,016 $68.2 Million
Q4 2022

Feb 09, 2023
SELL
$106.72 - $127.06 $9.72 Million - $11.6 Million
-91,049 Reduced 11.91%
673,718 $80.5 Million
Q3 2022

Nov 14, 2022
BUY
$92.03 - $107.81 $17.8 Million - $20.8 Million
193,015 Added 33.76%
764,767 $81.2 Million
Q2 2022

Aug 12, 2022
SELL
$75.79 - $100.07 $5.21 Million - $6.88 Million
-68,707 Reduced 10.73%
571,752 $55.7 Million
Q1 2022

May 13, 2022
BUY
$72.45 - $94.81 $3.15 Million - $4.12 Million
43,447 Added 7.28%
640,459 $60 Million
Q4 2021

Feb 08, 2022
SELL
$79.65 - $106.22 $6.47 Million - $8.63 Million
-81,261 Reduced 11.98%
597,012 $50.8 Million
Q3 2021

Nov 15, 2021
BUY
$86.18 - $99.03 $2.65 Million - $3.04 Million
30,718 Added 4.74%
678,273 $65.1 Million
Q2 2021

Aug 16, 2021
SELL
$89.43 - $102.27 $576,912 - $659,743
-6,451 Reduced 0.99%
647,555 $63 Million
Q1 2021

May 14, 2021
BUY
$87.57 - $119.4 $1.4 Million - $1.9 Million
15,949 Added 2.5%
654,006 $63.6 Million
Q4 2020

Feb 02, 2021
SELL
$86.91 - $108.33 $17.9 Million - $22.3 Million
-206,232 Reduced 24.43%
638,057 $61.2 Million
Q3 2020

Nov 05, 2020
SELL
$96.16 - $135.15 $1.23 Million - $1.72 Million
-12,747 Reduced 1.49%
844,289 $81.2 Million
Q2 2020

Jul 22, 2020
SELL
$85.09 - $130.36 $6.92 Million - $10.6 Million
-81,342 Reduced 8.67%
857,036 $105 Million
Q1 2020

May 06, 2020
BUY
$75.11 - $113.76 $22.2 Million - $33.7 Million
296,167 Added 46.12%
938,378 $81.2 Million
Q4 2019

Feb 03, 2020
SELL
$86.8 - $118.57 $6.8 Million - $9.3 Million
-78,397 Reduced 10.88%
642,211 $69 Million
Q3 2019

Nov 04, 2019
SELL
$83.82 - $101.5 $46.7 Million - $56.5 Million
-557,092 Reduced 43.6%
720,608 $64.9 Million
Q2 2019

Jul 30, 2019
BUY
$72.24 - $91.27 $14.1 Million - $17.8 Million
194,643 Added 17.97%
1,277,700 $108 Million
Q1 2019

May 09, 2019
SELL
$69.31 - $91.53 $15 Million - $19.8 Million
-216,398 Reduced 16.65%
1,083,057 $95.4 Million
Q4 2018

Feb 07, 2019
BUY
$68.32 - $124.36 $19 Million - $34.6 Million
278,598 Added 27.29%
1,299,455 $92.8 Million
Q3 2018

Oct 25, 2018
BUY
$98.88 - $125.85 $4.07 Million - $5.18 Million
41,186 Added 4.2%
1,020,857 $126 Million
Q2 2018

Aug 02, 2018
BUY
$75.3 - $105.99 $3.93 Million - $5.53 Million
52,200 Added 5.63%
979,671 $96.2 Million
Q1 2018

Apr 23, 2018
BUY
$75.88 - $92.43 $5.66 Million - $6.9 Million
74,636 Added 8.75%
927,471 $76.9 Million
Q4 2017

Feb 08, 2018
BUY
$58.53 - $77.59 $4.11 Million - $5.44 Million
70,150 Added 8.96%
852,835 $66.2 Million
Q3 2017

Oct 24, 2017
BUY
$47.97 - $61.28 $37.5 Million - $48 Million
782,685
782,685 $48 Million

Others Institutions Holding NBIX

# of Institutions
718
Shares Held
102M
Call Options Held
228K
Put Options Held
336K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $13.9B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email